The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated DegradationOlivier Mansier(Target (United States)), Éric Lippert(Inserm)CancersDecember 2, 201910.3390/cancers11121921Cited by 10SaveCiteExport RISWatch citationsRelated PapersEvaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies|eLife|2024|3Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies|eLife|2024|1Author response: Evaluation of Clonal Hematopoiesis and Mosaic Loss of Y Chromosome in Cardiovascular Risk: an analysis in prospective studies|Unknown|2024|0Author response: Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies|Unknown|2024|0